November 18, 2020
12 pm to 1 pm EST
In protein-based formulations, distinguishing aggregated API from other particle types is important for understanding the root cause of instability. Until now, existing methods have been either unreliable or too cumbersome and difficult to use
in many workflows. Here we introduce the Aura, a 96-well low-volume aggregate and particle imaging system that can rapidly size, count, and characterize particles and identify them as proteins, non-proteins, hydrophobic, or other types of
- Characterize aggregates that are not detected by other methods
- Identify the source of particles to develop the right mitigation approaches
- Classify particles as inherent, intrinsic, or extrinsic
- Characterize critical quality attributes early in development
- Use a USP compendial method to characterize stability throughout development
Rick Gordon, MS
Rick led the commercial launch of the Horizon system in 2017 and the Aura system in 2020 and currently supports their ongoing commercial development by assisting customers pre and post-purchase. Prior to this, Rick held similar positions at Unchained
Labs, ForteBio, and Molecular Devices. Rick holds degrees from the University of Washington and the University of Maine and has scientific training in tumor immunology and cell biology.
Cost: No Cost!